Tech innovator Thunder Energies Corporation’s (OTCQB: TNRG) announcement that it has successfully built the Santilli Telescope, the very first optical instrument that can detect antimatter particles, has introduced many changes in the world of science and astronomy. And now, because of these changes, a lot of people have become more interested in the company, asking if knowing more about these elusive particles could really affect human lives.

The thing is, antimatters are an essential aspect of modern medicine. Latest studies on antimatters revealed that it has the potential to cure fatal diseases like cancer.

In 2003, scientists at Geneva-based CERN started their work on determining if antimatters can really cure cancer as early theories hypothesized. The Antiproton Cell Experiment at CERN is the first ever formal research and study on the biological effects of antiprotons.

Eight years later, in 2011, this group of scientists said that it was now possible to trap the entire atoms of antimatters for over 16 minutes, the longest time recorded on holding on to antimatter atoms. Trapping antimatters for a long period of time, as the group suggested it, could lead to unraveling the effectuality of protons and antiprotons in battling cancer cells.

Also, according to experts at CERN, targeting tumors with beams of particles that will release their energy after safely passing through healthy tissue could soon be possible in the future. In earlier studies, they found out that antiprotons could do this if powered by extra bursts of energy.


This is highly possible, according to writer Richard Stockton, as antimatters annihilate when touched.

“Antimatter collisions generate gamma ray photons, which are the most energetic ionizing radiation we know about. If you were in a room with a gamma ray emitter, that puny lead apron the dentist gives you would be less use than a flak jacket made out of toilet paper,” he wrote.

However, scientists across the globe are still conducting their own researches and studies on its true capability to cure such a baffling disease. But experts are confident that the recent advancements in the segment could soon lead to a positive result, which could include treating fatal diseases other than cancer.


Photo credit:

Currently, antimatters are heavily used in tomography, or the medical method of capturing images of single tissue planes by penetrating waves. Positron Emission Tomography (PET), a type of medical test that utilizes a special type of camera and a tracer (radioactive chemical) to look at organs in the body, is used by oncologists to locate tumors inside the brain. This is done by injecting a radioactive isotope into the bloodstream and produces positrons.


“[PET] consists of a positron-emitting radioactive isotope linked to a biologically active molecule. The antimatter it releases is not detected directly but by virtue of the pairs of gamma rays it sends out when each positron encounters an electron. Depending on the tracer molecule, different metabolic processes can be highlighted, such as oxygen use in the brain,” explained on its article Making Antimatter and Putting it to Use.

The good news is that the search for antimatters’ possible capability to cure fatal diseases remains one of the main priorities of many scientists across the globe.